These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Adverse drug reactions in special populations - the elderly. Davies EA; O'Mahony MS Br J Clin Pharmacol; 2015 Oct; 80(4):796-807. PubMed ID: 25619317 [TBL] [Abstract][Full Text] [Related]
3. Frailty: a key indicator to minimize inappropriate medication in older people. Poudel A; Hubbard RE; Nissen L; Mitchell C QJM; 2013 Oct; 106(10):969-75. PubMed ID: 23824943 [TBL] [Abstract][Full Text] [Related]
4. Frailty in older inpatients: what physicians need to know. McMillan GJ; Hubbard RE QJM; 2012 Nov; 105(11):1059-65. PubMed ID: 22753676 [TBL] [Abstract][Full Text] [Related]
5. Use of a frailty index to identify potentially inappropriate prescribing and adverse drug reaction risks in older patients. Cullinan S; O'Mahony D; O'Sullivan D; Byrne S Age Ageing; 2016 Jan; 45(1):115-20. PubMed ID: 26683048 [TBL] [Abstract][Full Text] [Related]
6. Multiple medication use in older patients in post-acute transitional care: a prospective cohort study. Runganga M; Peel NM; Hubbard RE Clin Interv Aging; 2014; 9():1453-62. PubMed ID: 25214773 [TBL] [Abstract][Full Text] [Related]
7. Polypharmacy: the challenge for nurses. Kaufman G Nurs Stand; 2016 May; 30(39):52-60. PubMed ID: 27224631 [TBL] [Abstract][Full Text] [Related]
8. Family conferences and shared prioritisation to improve patient safety in the frail elderly (COFRAIL): study protocol of a cluster randomised intervention trial in primary care. Mortsiefer A; Wilm S; Santos S; Löscher S; Wollny A; Drewelow E; Ritzke M; Thürmann P; Mann NK; Meyer G; Abraham J; Icks A; Montalbo J; Wiese B; Altiner A; Trials; 2020 Mar; 21(1):285. PubMed ID: 32197631 [TBL] [Abstract][Full Text] [Related]
9. Prescribing in the oldest old inpatients: a retrospective analysis of patients referred for specialist geriatric consultation. Ilango S; Pillans P; Peel NM; Scott I; Gray LC; Hubbard RE Intern Med J; 2017 Sep; 47(9):1019-1025. PubMed ID: 28632340 [TBL] [Abstract][Full Text] [Related]
10. Medication Management in Frail Older People: Consensus Principles for Clinical Practice, Research, and Education. Liau SJ; Lalic S; Sluggett JK; Cesari M; Onder G; Vetrano DL; Morin L; Hartikainen S; Hamina A; Johnell K; Tan ECK; Visvanathan R; Bell JS; J Am Med Dir Assoc; 2021 Jan; 22(1):43-49. PubMed ID: 32669236 [TBL] [Abstract][Full Text] [Related]
11. [Pharmacotherapeutic care for vulnerable groups with polypharmacy has to get better]. Lemmens LC; Delwel GO; Meijler AP; Weda M Tijdschr Gerontol Geriatr; 2015 Sep; 46(4):189-95. PubMed ID: 25987444 [TBL] [Abstract][Full Text] [Related]
12. Medication use in older patients and age-blind approach: narrative literature review (insufficient evidence on the efficacy and safety of drugs in older age, frequent use of PIMs and polypharmacy, and underuse of highly beneficial nonpharmacological strategies). Fialová D; Laffon B; Marinković V; Tasić L; Doro P; Sόos G; Mota J; Dogan S; Brkić J; Teixeira JP; Valdiglesias V; Costa S; Eur J Clin Pharmacol; 2019 Apr; 75(4):451-466. PubMed ID: 30610276 [TBL] [Abstract][Full Text] [Related]
13. How do potentially inappropriate medications and polypharmacy affect mortality in frail and non-frail cognitively impaired older adults? A cohort study. Porter B; Arthur A; Savva GM BMJ Open; 2019 May; 9(5):e026171. PubMed ID: 31092652 [TBL] [Abstract][Full Text] [Related]
14. Characteristics of outpatient prescriptions for frail Taiwanese elders with long-term care needs. Chan DC; Hao YT; Wu SC Pharmacoepidemiol Drug Saf; 2009 Apr; 18(4):327-34. PubMed ID: 19180586 [TBL] [Abstract][Full Text] [Related]
15. Adverse Outcomes in Relation to Polypharmacy in Robust and Frail Older Hospital Patients. Poudel A; Peel NM; Nissen LM; Mitchell CA; Gray LC; Hubbard RE J Am Med Dir Assoc; 2016 Aug; 17(8):767.e9-767.e13. PubMed ID: 27373672 [TBL] [Abstract][Full Text] [Related]
16. Multimorbidity patterns in chronic older patients, potentially inappropriate prescribing and adverse drug reactions: protocol of the multicentre prospective cohort study MoPIM. Baré M; Herranz S; Jordana R; Gorgas MQ; Ortonobes S; Sevilla D; De Jaime E; Ibarra O; Martín C; BMJ Open; 2020 Jan; 10(1):e033322. PubMed ID: 31988230 [TBL] [Abstract][Full Text] [Related]
17. Is my older cancer patient on too many medications? Turner JP; Shakib S; Bell JS J Geriatr Oncol; 2017 Mar; 8(2):77-81. PubMed ID: 27840102 [TBL] [Abstract][Full Text] [Related]
18. Algorithm of medication review in frail older people: Focus on minimizing the use of high-risk medications. Poudel A; Ballokova A; Hubbard RE; Gray LC; Mitchell CA; Nissen LM; Scott IA Geriatr Gerontol Int; 2016 Sep; 16(9):1002-13. PubMed ID: 26338275 [TBL] [Abstract][Full Text] [Related]
19. Interventions to improve medicines optimisation in frail older patients in secondary and acute care settings: a systematic review of randomised controlled trials and non-randomised studies. Saeed D; Carter G; Parsons C Int J Clin Pharm; 2022 Feb; 44(1):15-26. PubMed ID: 34800255 [TBL] [Abstract][Full Text] [Related]
20. Deprescribing in multi-morbid older people with polypharmacy: agreement between STOPPFrail explicit criteria and gold standard deprescribing using 100 standardized clinical cases. Curtin D; Dukelow T; James K; O'Donnell D; O'Mahony D; Gallagher P Eur J Clin Pharmacol; 2019 Mar; 75(3):427-432. PubMed ID: 30421220 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]